Medline, Inc. SG&A increased by 14.8% to $1.23B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.8%, from $1.07B to $1.23B. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
Increases may indicate aggressive marketing or expansion, while decreases often reflect cost-cutting measures or improved corporate efficiency.
Detailed definition
The sum of all direct and indirect selling expenses and all general and administrative expenses of a company. This inclu...
Peer comparison
Used to assess the 'leaness' of a company's corporate structure relative to its peers.
Metric ID:
selling_general_and_administrativeHistorical Data
10 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $966.75M | $966.75M | $966.75M | $966.75M | $1.03B | $1.03B | $1.03B | $1.03B | $1.07B | $1.23B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +6.2% | +0.0% | +0.0% | +0.0% | +4.2% | +14.8% |
| YoY Change | — | — | — | — | +6.2% | +6.2% | +6.2% | +6.2% | +4.2% | +14.8% |
Range$966.75M – $1.23B
CAGR+11.2%
Avg YoY Growth+7.3%
Median YoY Growth+6.2%
Current Streak9+ quarters growth
SG&A at Other Companies
Frequently Asked Questions
- What is Medline, Inc. 's sg&a?
- Medline, Inc. (MDLN) reported sg&a of $1.23B in Q1 2026.
- How has Medline, Inc. 's sg&a changed year-over-year?
- Medline, Inc. 's sg&a increased by 14.8% year-over-year, from $1.07B to $1.23B.
- What does sg&a mean?
- The day-to-day costs of running the business and marketing its products.